CIHR’s Institute of Infection & Immunity (III) engaged Shift Health to support the development of a 5-year strategic plan that reflected the research interests and strengths of Canada’s infection and immunity research community and the implications of the COVID-19 pandemic.
The Saudi Government aimed to create a national health research agency to strengthen the research and innovation ecosystem, support a learning healthcare system and diversify the Kingdom’s knowledge economy.
Cancer research stakeholders across Canada recognized the need for a unifying vision that would inspire collective action and prepare Canada for leadership in a rapidly evolving cancer research landscape.
Shift Health was engaged to support a top-5 global pharmaceutical company in defining its role and priorities in the evolving HIV disease management landscape.
Shift Health and University Health Network (UHN) were engaged by Halton Healthcare to assess the current state of research across a multisite hospital system and define the future direction of its clinical research program.
The International AIDS Society (IAS) required support to develop a 5-year strategy for the Global HIV Vaccine Enterprise (the Enterprise)—a long-time convenor and facilitator for the HIV vaccine R&D field.
McMaster University sought to establish a Canadian network focused on advancing innovative solutions to drug-resistant infections.